-
article incorporates text from this source,
which is in the
public domain.
Waknine Y (8 May 2008). "FDA Approvals: Advair, Relistor, Aplenzin". Medscape....
- 1 (2): 137–42. doi:10.3978/j.issn.2224-5820.2012.07.09. PMID 25841474.
Waknine, Yael (April 6, 2007). "FDA Bans
Suppositories With Trimethobenzamide"...
-
Archived from the
original on 8
September 2017.
Retrieved 17
September 2017.
Waknine Y (22
September 2006). "First-Time
Generic Approvals: Seasonale, Imodium...
- Ther. 24 (7): 1117–33. doi:10.1016/S0149-2918(02)80023-6. PMID 12182256.
Waknine Y (1
December 2006). "FDA Approvals: Ziana, Kadian,
Polyphenon E". Medscape...
- were
allegedly funneled through ****ociates
including Suge
Knight and Hai
Waknine. As a result,
Nazarian was
granted only a one-year
limited gaming license...
- 69 (3): 307–317. doi:10.2165/00003495-200969030-00006. PMID 19275274.
Waknine Y (4
September 2008). "FDA Approvals: Nplate, Aloxi, Vidaza". Medscape...
- Health-System Pharmacy. 64 (18): 1917–1921. doi:10.2146/ajhp060414. PMID 17823102.
Waknine Y (13
April 2007). "Prescribers
Warned of
Tizanidine Drug Interactions"...
-
Administration (FDA).
Archived from the
original (PDF) on 27
September 2007.
Waknine Y (14
November 2006). "Tamiflu May Be
Linked to Risk for Self-Injury and...
- 170–177. doi:10.1016/j.clpt.2004.10.005. PMID 15735611. S2CID 24716662. Yael
Waknine (1
January 2007). "FDA
Safety Changes: Allegra, Cymbalta, Concerta". Medscape...
- (12): 1784–93. doi:10.1592/phco.26.12.1784. PMID 17125439. S2CID 24150415.
Waknine Y (5
September 2008). "FDA
Safety Changes: Mirena, Zyvox, Orencia". Medscape...
